The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe

Annals of Oncology

Volumn 20, Issue 4, 2009, Pages 767-774

  Bosetti, C ^a   Levi, F ^b   Ferlay, J ^c   Lucchini, F ^b   Negri, E ^a   La Vecchia, C ^a,d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Europe; Hodgkin lymphoma; Incidence; Mortality; Trends

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; EUROPE; EUROPEAN UNION; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK REDUCTION;

EUROPE; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MORTALITY;

EID: 63549137646     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn673     Document Type: Article

References (26)

1. Levi F, Lucchini F, Negri E et al. Trends in mortality from Hodgkin's disease in western and eastern Europe. Br J Cancer 2002; 87: 291-293.
2. Bosetti C, Bertuccio P, Levi F et al. Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol 2008; 19: 631-640.
3. World Health Organization Statistical Information System. WHO Mortality Database. 2007 http://www3.who.int/whosis/menu.cfm (accessed November 2007).
4. World Health Organization. International Classification of Disease: 8th revision. Geneva: World Health Organization 1967.
5. World Health Organization. International Classification of Disease: 9th revision. Geneva: World Health Organization 1977.
6. World Health Organization. International Statistical Classification of Disease and related Health Problems: 10th revision. Geneva: World Health Organization 1992.
7. Doll R, Smith PG. Comparison between registries: Age-standardized rates. Vol. IV. IARC Sci Publ No. 42. In Waterhouse JAH, Muir CS, Shanmugaratnam K et al. (eds): Cancer Incidence in Five Continents. Lyon: IARC 1982; 671-675.
8. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Volume I to VIII. [Cancer base No.7]. Lyon, France: International Agency for Research on Cancer 2005.
9. Engholm G, Storm HH, Ferlay J et al. NORDCAN: Cancer Incidence and Mortality in the Nordic Countries, Version 3.0. Association of Nordic Cancer Registries. Danish Cancer Society. 2007 http://www.ancr.nu (accessed September 2007).
10. Swedish Cancer Registry. http://www.socialstyrelsen.se/ (accessed October 2006).
11. Information Services Division (ISD). www.isdscotland.org (accessed April 2007).
12. National Statistics. http://www.statistics.gov.uk (accessed April 2007).
13. Dutch Comprehensive Cancer Centres. http://www.iKCnet.nl (accessed October 2006).
14. Institute of Oncology Ljubljana. http://www.onko-i.si/en/ sectors_of_the_institute_of_oncology/epidemiolog/ (accessed September 2007).
15. National Cancer Registry Ireland. http://www.ncri.ie/ncri (accessed February 2008).
16. Ondrusova M, Plesko I, Safaei-Diba Ch et al. Comprehensive Analysis of Incidence and Mortality in the Slovak Republic, 1978-2003. Bratislaba: National Health Information Center of the Slovak Republic, [cit. 2007-10-01] 2007 http://www-nor-sk.org (accessed September 2007).
17. Adamson P, Bray F, Costantini AS et al. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 2007; 43: 391-401.
18. Karim-Kos HE, de Vries E, Soerjomataram I et al. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. Eur J Cancer 2008.
19. Gil-Delgado MA, Khyat D, Johnson SAN. Chapter 30. Lymphomas. In Pollock RE (ed): UICC Manual of Clinical Oncology, Eighth Edition. Hoboken, New Jersey: John Wiley & Sons, Inc 2004; 671-689.
20. Mueller NE, Grufferman S. Hodgkin lymphoma. In Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, 3rd edition. New York: Oxford University Press 2006; 872-897.
21. Diehl V. Hodgkin's disease - from pathology specimen to cure. N Engl J Med 2007; 357: 1968-1971.
22. Cheson BD, Pfistner B, Juweid ME et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
23. Fermé C, Eghbali H, Meerwaldt JH et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med 2007; 357: 1916-1927.
24. Maucort-Boulch D, Djeridane M, Roy P et al. Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas. Cancer 2007; 109: 256-264.
25. Han X, Kilfoy B, Zheng T et al. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control 2008.
26. Levi F, Lucchini F, Negri E et al. Trends in mortality from leukemia in subsequent age groups. Leukemia 2000; 14: 1980-1985.